SIGN UP LOGIN    
Hellixmith Co., Ltd
Country Korea, South
Tel +82-2-2102-7238
URL www.helixmith.com

EXHIBITION    KOREA PHARM & BIO 2022

Booth No. 7C106
last updated on ( 2022-05-23 )

*. Helixmith Co.,Ltd. Helixmith has been devoted to gene therapy research since its establishment in 1996, leading innovation through next-generation gene therapy products. Helixmith’s lead gene therapy product in the biologics business is Engensis (VM202), a plasmid DNA treatment. We will continue to strengthen our pipelines with new technologies and knowledge to maintain a high growth and create a high revenue business. In addition, we plan to expand the Phytotherapeutics business and CGT business. *. Helixmith CGT business(CDMO) Our CGT Plant was established on the 4th floor of Magok headquarters in Seoul in September 2021 with the aim of manufacturing cell therapy and viral vector and customized CDMO services. At the request of the client company, we provide customized services from the initial development stage. If you are worried about the lack of cell therapy and viral vector production facilities and management know-how, contact our CGT business division.

more

EXHIBIT

COMPANY INTRODUCTION

*. Helixmith Co.,Ltd. Helixmith has been devoted to gene therapy research since its establishment in 1996, leading innovation through next-generation gene therapy products. Helixmith’s lead gene therapy product in the biologics business is Engensis (VM202), a plasmid DNA treatment. We will continue to strengthen our pipelines with new technologies and knowledge to maintain a high growth and create a high revenue business. In addition, we plan to expand the Phytotherapeutics business and CGT business. *. Helixmith CGT business(CDMO) Our CGT Plant was established on the 4th floor of Magok headquarters in Seoul in September 2021 with the aim of manufacturing cell therapy and viral vector and customized CDMO services. At the request of the client company, we provide customized services from the initial development stage. If you are worried about the lack of cell therapy and viral vector production facilities and management know-how, contact our CGT business division.

QUICK LINK

Inquiry

Sender
/
Purpose *
Available Amount for a deal *
Details

SHARE

SHARE

REQUEST THE VIDEO MEETING

  • (KST, UTC+09:00)

    This above time is Korean local time.
    The time for meeting is based on Korean local time.
    Please check Korean time, and choose the time available.
Sender
/ 푸디스트 주식회사
Receiver
김우성 / Hellixmith Co., Ltd
Purpose *
Available Amount for a deal *
Date *
Time *
Attendee 1 *
Attendee 2
Massage